Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02655250 · ClinicalTrials.gov registry record

Neonatal Microbiome Validity Study

A clinical trial, sponsored by State University of New York at Buffalo.

Completed
Registry status
5
Enrollment target

NCT02655250: Completed study, sponsored by State University of New York at Buffalo.

NCT02655250 is a clinical trial that has completed, run by State University of New York at Buffalo. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02655250 has completed, sponsored by State University of New York at Buffalo.

COMPLETED
Registry status
5 participants
Enrollment target

Study Summary

This is a validation study to compare proposed field collection methods with a gold standard collection technique for microbiome analysis of stool and breast milk samples.

Primary Outcome

Comparison of microbiome from snap-frozen sample (gold standard) to proposed field collection methods to determine which field method best correlates with the snap-frozen sample.

Interventions

  • OTHER Microbiome

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2015-10
Est. Completion 2017-12

What the finished NCT02655250 record still lists

NCT02655250 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Microbiome is the first listed.

NCT02655250 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02655250 about?

NCT02655250 is a clinical study titled "Neonatal Microbiome Validity Study". This is a validation study to compare proposed field collection methods with a gold standard collection technique for microbiome analysis of stool and breast milk samples.

What is the current status of trial NCT02655250?

This trial is currently completed. The enrollment target is 5 participants. The study started on 2015-10. Estimated completion is 2017-12.

What interventions are being tested in trial NCT02655250?

The interventions under investigation include: Microbiome (OTHER).

Who is sponsoring clinical trial NCT02655250?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02655250, the US trial registry maintained by the National Library of Medicine. NCT02655250 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.